Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily L Hopewell

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Molecular Therapy. Methods & Clinical Development|February 15, 2020
Manufacturing Dendritic Cells for Immunotherapy: Monocyte EnrichmentEmily L Hopewell, Cheryl Cox
Cytotherapy|December 5, 2018
Tumor-infiltrating lymphocytes: Streamlining a complex manufacturing processEmily L Hopewell, Cheryl Cox, Shari Pilon-Thomas, et al.
Cytotherapy|September 25, 2023
Survey of genetic counselors identifies a knowledge gap discerning properly regulated cell and gene therapy trialsLily A Geiselman, Leah Wetherill, Brett H Graham, et al.
European Journal of Immunology|December 14, 2011
IKKβ-induced inflammation impacts the kinetics but not the magnitude of the immune response to a viral vectorEmily L Hopewell, Crystina C Bronk, Michael Massengill, et al.
European Journal of Immunology|September 25, 2014
NF-κB is crucial in proximal T-cell signaling for calcium influx and NFAT activationCrystina C Bronk, Sean Yoder, Emily L Hopewell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 25, 2014
Differential requirement for the IKKβ/NF-κB signaling module in regulating TLR- versus RLR-induced type 1 IFN expression in dendritic cellsXingyu Wang, Junmei Wang, Hong Zheng, et al.
The Journal of Clinical Investigation|May 3, 2013
Lung tumor NF-κB signaling promotes T cell-mediated immune surveillanceEmily L Hopewell, Weipeng Zhao, William J Fulp, et al.
Cancer Immunology, Immunotherapy : CII|September 14, 2018
A phase I/randomized phase II study of GM.CD40L vaccine in combination with CCL21 in patients with advanced lung adenocarcinomaJhanelle E Gray, Alberto Chiappori, Charlie C Williams, et al.
Transplantation and Cellular Therapy|February 28, 2026
Advancing Cell Therapies for Solid Tumors: A Pathway to Overcome Biological, Operational, and Regulatory HurdlesKedar Kirtane, Michael Kalos, Rocky Billups, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Molecular Therapy. Methods & Clinical Development|February 15, 2020
Manufacturing Dendritic Cells for Immunotherapy: Monocyte EnrichmentEmily L Hopewell, Cheryl Cox
Cytotherapy|December 5, 2018
Tumor-infiltrating lymphocytes: Streamlining a complex manufacturing processEmily L Hopewell, Cheryl Cox, Shari Pilon-Thomas, et al.
Cytotherapy|September 25, 2023
Survey of genetic counselors identifies a knowledge gap discerning properly regulated cell and gene therapy trialsLily A Geiselman, Leah Wetherill, Brett H Graham, et al.
European Journal of Immunology|December 14, 2011
IKKβ-induced inflammation impacts the kinetics but not the magnitude of the immune response to a viral vectorEmily L Hopewell, Crystina C Bronk, Michael Massengill, et al.
European Journal of Immunology|September 25, 2014
NF-κB is crucial in proximal T-cell signaling for calcium influx and NFAT activationCrystina C Bronk, Sean Yoder, Emily L Hopewell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 25, 2014
Differential requirement for the IKKβ/NF-κB signaling module in regulating TLR- versus RLR-induced type 1 IFN expression in dendritic cellsXingyu Wang, Junmei Wang, Hong Zheng, et al.
The Journal of Clinical Investigation|May 3, 2013
Lung tumor NF-κB signaling promotes T cell-mediated immune surveillanceEmily L Hopewell, Weipeng Zhao, William J Fulp, et al.
Cancer Immunology, Immunotherapy : CII|September 14, 2018
A phase I/randomized phase II study of GM.CD40L vaccine in combination with CCL21 in patients with advanced lung adenocarcinomaJhanelle E Gray, Alberto Chiappori, Charlie C Williams, et al.
Transplantation and Cellular Therapy|February 28, 2026
Advancing Cell Therapies for Solid Tumors: A Pathway to Overcome Biological, Operational, and Regulatory HurdlesKedar Kirtane, Michael Kalos, Rocky Billups, et al.
Pageof 1